Skip to main content
Contact Us
Subscribe
E-Edition
64°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SRPT
Recent news which mentions SRPT
< Previous
1
2
3
4
5
6
7
8
9
Next >
Sarepta Therapeutics (SRPT) Q4 2022 Earnings Call Transcript
February 28, 2023
Tickers
SRPT
Tags
SRPT
Recent Press Releases
Market News
From
Motley Fool
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
Tickers
BIIB
EWTX
RETA
SPX
Tags
SPX
XPH
RETA
From
MarketWatch
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 28, 2023
Tickers
BLPH
CBIO
CPHI
CUTR
Tags
SDGR
SRPT
NVAX
From
Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
Tickers
NFE
NNI
NRDY
NSTG
Tags
VRM
SLRC
WRBY
From
Benzinga
Expert Ratings for Sarepta Therapeutics
February 15, 2023
Tickers
SRPT
Tags
BZI/AAR
Analyst Ratings
Benzinga
From
Benzinga
3 Gene Editing Stocks With the Best Long-Term Potential
January 25, 2023
Tickers
CRSP
GNOM
MYGN
NTLA
Tags
NASDAQ:CRSP,NASDAQ:GNOM,NASDAQ:NTLA,NASDAQ:MYGN,NASDAQ:SRPT
GNOM
MYGN
From
InvestorPlace
9 Analysts Have This to Say About Sarepta Therapeutics
January 20, 2023
Tickers
SRPT
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
7 Biotech Stocks That Will Make You Rich in 10 Years
January 18, 2023
Tickers
ABBV
CRSP
CVAC
DIS
Tags
ABBV
CRSP
EXEL
From
InvestorPlace
2 Under-the-Radar Biotech Stocks to Buy in 2023
January 06, 2023
Tickers
CRSP
SRPT
VRTX
Tags
CRSP
SRPT
Market News
From
Motley Fool
BTIG Maintains Buy Rating for Sarepta Therapeutics: Here's What You Need To Know
December 22, 2022
Tickers
SRPT
Tags
Analyst Ratings
Benzinga
BZI/AAR/UPDATE
From
Benzinga
2 Top Healthcare Stocks to Buy for the Long Haul
December 09, 2022
Tickers
AZN
GH
SRPT
Tags
GH
Market News
Recent Press Releases
From
Motley Fool
Analyst Ratings for Sarepta Therapeutics
November 03, 2022
Tickers
SRPT
Tags
Analyst Ratings
BZI/AAR
Benzinga
From
Benzinga
Sarepta Therapeutics (SRPT) Q3 2022 Earnings Call Transcript
November 03, 2022
Tickers
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
Earnings Scheduled For November 2, 2022
November 02, 2022
Tickers
QMCO
QRVO
RACE
RARE
Tags
SRI
Earnings Scheduled
SPNT
From
Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
October 29, 2022
Tickers
DNA
NVCR
SRPT
Tags
NVCR
DNA
SRPT
From
Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2022
October 19, 2022
Tickers
CRSP
SRPT
Tags
SRPT
Recent Press Releases
Market News
From
Motley Fool
Apple To $177? Plus This Analyst Slashes PT On Opendoor Technologies By About 71%
October 17, 2022
Tickers
AAPL
BILL
LIN
OPEN
Tags
Markets
LIN
Benzinga
From
Benzinga
7 Analysts Have This to Say About Sarepta Therapeutics
October 13, 2022
Tickers
SRPT
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
September 28, 2022
Tickers
PEPG
SRPT
Tags
Trading Ideas
Analyst Color
Reiteration
From
Benzinga
$6 Million Bet On Sarepta Therapeutics? 3 Stocks Insiders Are Buying
September 16, 2022
Tickers
CNA
COIN
SRPT
Tags
Markets
Market News
CNA
From
Benzinga
Analyst Ratings for Sarepta Therapeutics
September 08, 2022
Tickers
SRPT
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
A Biotech's Stock Just Hit Year High. This Analyst Expects It To Jump Another 16%
September 08, 2022
Tickers
SRPT
Tags
Health Care
General
News
From
Benzinga
FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial
September 06, 2022
Tickers
SRPT
Tags
FDA
General
News
From
Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
August 29, 2022
Tickers
CRSP
MYGN
SRPT
Tags
SRPT
Recent Press Releases
Market News
From
Motley Fool
Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications
August 08, 2022
Tickers
SRPT
Tags
Market News
SRPT
Biotech
From
Benzinga
Is Biotech Back? This Analyst Sees 18% Upside Potential In This Bio Play
August 08, 2022
Tickers
SRPT
Tags
SRPT
Biotech
Market News
From
Benzinga
Sarepta's Duchenne Gene Therapy Update Gets Bullish Stance From Analysts
August 03, 2022
Tickers
SRPT
Tags
Analyst Ratings
Market News
Price Target
From
Benzinga
Sarepta Therapeutics (SRPT) Q2 2022 Earnings Call Transcript
August 02, 2022
Tickers
SRPT
Tags
Market News
Recent Press Releases
SRPT
From
Motley Fool
Sarepta Therapeutics: Q2 Earnings Insights
August 02, 2022
Tickers
SRPT
Tags
Earnings
Benzinga
BZI/Recaps
From
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Tickers
ABBV
ACIU
ALLR
AXLA
Tags
VALN
AXLA
Movers
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.